Kimberly Benton, PhD – Dr. Benton is the Deputy Director, Division of Cellular and Gene Therapies at the Center for Biologics Evaluation and Research, FDA. Her duties focus on oversight of review and regulatory activities and policy development for cellular therapy, gene therapy, xenotransplantation, related products such as therapeutic vaccines, and combination products involving cell or gene therapies. In DCGT, Dr. Benton first served as a Staff Fellow and subsequently became a Chemistry, Manufacturing, and Controls Reviewer of somatic cell therapies. She was the Chief of the Cell Therapies Branch prior to her current position as the Deputy Director of the Division of Cellular and Gene Therapies.


Dr. Benton was mentored by Dr. David Briles.